Prilenia Company

Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders.
Technology: Small Molecules
Industry: Geroscience
Headquarters: Herzliya, Tel Aviv, Israel
Founded Date: 2018-01-01
Employees Number: 11-50
Investors Number: 8
Total Funding: 105500000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-11-03
Last Funding Type: Series B

Visit Website
Register and Claim Ownership